Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Navidea Biopharmaceuticals Inc    

NAVIDEA BIOPHARMACEUTICALS INC
Mes dernières consult.
Most popular
Report
No quotes available
-- USD   --.--%
08/09 NAVIDEA BIOPHAR : reports 2Q loss
05/16 NAVIDEA BIOPHAR : NAVB) Files An 8-K Other Events
05/10 NAVIDEA BIOPHAR : posts 1Q profit
 SummaryNewsCalendarCompanyFinancials 
Company
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic.It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on NAVIDEA BIOPHARMACEUTICALS
10/13 NAVIDEA BIOPHARMACEUTICALS, INC. : Change in Directors or Principal Officers (fo..
09/07 NAVIDEA BIOPHARMACEUTICALS : To Initiate Regular Webcast Series Featuring Modera..
08/09 NAVIDEA BIOPHARMACEUTICALS : Management's Discussion and Analysis of Financial C..
08/09 NAVIDEA BIOPHARMACEUTICALS, INC. : Results of Operations and Financial Condition..
08/09 NAVIDEA BIOPHARMACEUTICALS : reports 2Q loss
06/30 NAVIDEA BIOPHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security H..
06/29 NAVIDEA BIOPHARMACEUTICALS, INC. : Other Events (form 8-K)
05/16 NAVIDEA BIOPHARMACEUTICALS, INC. (NY : NAVB) Files An 8-K Other Events
05/16 NAVIDEA BIOPHARMACEUTICALS, INC. : Other Events (form 8-K)
05/10 NAVIDEA BIOPHARMACEUTICALS : Management's Discussion and Analysis of Financial C..
More news
Sector news : Biotechnology & Medical Research - NEC
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
09/30 3 THINGS IN BIOTECH YOU SHOULD LEARN : September 30, 2017
09/13 Navidea Biopharm (NAVB) Presents At Rodman & Renshaw 19th Annual Global Inves..
09/02 Stocks to watch next week
08/09 Navidea Biopharm reports Q2 results
07/05 DAILY INSIDER RATINGS ROUND UP 7/3/1 : Mcc, cnbka, opk, cara, kfs, mmac
Income Statement Evolution
Managers
NameTitle
Mike M. Goldberg President, Chief Executive Officer & Director
Eric K. Rowinsky Chairman
Jed Andrew Latkin CFO, COO, Secretary & Treasurer
Frederick O. Cope Chief Scientific Officer & Senior Vice President
Mark I. Greene Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NAVIDEA BIOPHARMACEUTICALS INC67
INCYTE CORPORATION13.88%24 054
QUINTILES IMS HOLDINGS INC35.48%22 162
LONZA GROUP57.01%19 392
CELLTRION, INC.--.--%19 297
ALNYLAM PHARMACEUTICALS, INC.206.36%10 522